I) Studies on the antiplasmic activity of some antiplasmic agents i) A new method of determination of plasmin activity
In most methods of determining plasmin activity, fibrinogen or fibrin is used as the substrate of plasmin. The lysis time or lysis area is measured to determine plasmin activity on these methods. But it is difficult for clinicians to determine the proper plasmin activity if they are not skilfull in determining the plasmin activity on these methods.
To remove this defect an attempt was made to devise a simple and rapid method on the determination of plasmin activity. It was tried to form a fibrin clot fixed with the pigment.
Using this substrate, a released quantity of the pigment from this clot was measured with spectrophotometer on fibrinolysis by plasmin. The present paper describes about the possibility of determination of plasmin activity on this method used this fibrin clot fixed with the pigment.
1) Blue Dextran with high molecular weight can be fixed with fibrin clot, but Methylene Blue cannot be fixed.
2) The fibrin clot fixed with Blue Dextran can be used as a substrate on this measurement of plasmin activity.
3) Plasmin activity was assayed by measuring the released quantity of Blue Dextran from the fibrin clot fixed with Blue Dextran by fibrinolysis.
4) On the measurement of the purified hunam plasmin activity, the determination on TAME esterolysis was correlated with a released quantity of Blue Dextran on this method using the fibrin clot fixed with Blue Dextran.
ii) Effects of some antiplasmic agents on human plasmin,
in vitroIn otorhinolaryngological treatment, the antiplasmic therapy has recently increased in order to inhibit the fibrinolysis which is induced by inflammation or by the surgical operation. Prior to using some antiplasmic agents in clinical treatment, these antifibrinolytic activities were estimated
in vitro. On fibrin plate method, t-AMCHA inhibited the UK-activated fibrinolysis, that is, plasminogen activation process induced by urokinase. The concentration of t-AMCHA for 100 % inhibition was 1.59×10
-1 M in order to inhibit plasminogen activation induced by urokinase (2.5 Ploug units). In the experiment of using the fibrin clot fixed with Blue Dextran, both t-AMCHA and CEP-t-AMCHA inhibited the fibrinolysis induced by the SK-activated plasmin. Inhibitory effect of CEP-t-AMCHA was more powerful than inhibitory effect of t-AMCHA.
II) Fibrinolytic activity in blood on sinectomy with and without the medication of the antiplasmic agents
It is well known that the fibrinolysis in blood has been induced by a various surgical operations. It is thought that the bleeding during and after the surgery might be attributable to the fibrinolysis. In order to decrease the bleeding induced by the fibrinolysis, the antiplasmic agent was given to the patients who underwent the sinectomy.
The present paper describes about the fibrinolytic activity in blood on sinectomy with and without the medication, of the antiplasmic agent.
1) The fibrinolytic activity was measured by affinity chromatography using Lysine-Sepharose.
2) In a group with the medication, the quantity of fibrinogen increased more than in a group without the medication after the sinectomy.
3) In a group with the medication, the quantity of plasminogen slightly decreased more than in a group without the medication after sinectomy.
抄録全体を表示